MedTrace Logo

The Effects of DPPIs on Cognitive Function of Diabetic Patients

NCT06164535 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2023-12-11

No results posted yet for this study

Summary

This is a single-center, randomized controlled clinical trial with a parallel-group design conducted at Minia University hospital.

Conditions

Interventions

DRUG

Control group

35 T2DM patients will be given placebo (only adjust their drugs to control blood glucose level)

DRUG

DPP-4 inhibitor group

35 T2DM patients will be given DPP-4 I once or twice daily

DRUG

DPP-4 inhibitor + metformin group

35 T2DM patients will be given DPP-4 I + metformin once or twice daily

Sponsors & Collaborators

  • Clinical Pharmacy Department, Faculty of Pharmacy, 6 October University

    collaborator UNKNOWN

  • Faculty of Medicine, Minia University

    collaborator UNKNOWN

  • Beni-Suef University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-30
Primary Completion
2024-06-30
Completion
2024-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06164535 on ClinicalTrials.gov